Humira Drug Global Market Report 2024

Description

Humira, or adalimumab, is an injectable medication prescribed for the treatment of rheumatoid arthritis and other related conditions. These drugs are utilized to alleviate pain and reduce swelling associated with various types of arthritis.

The primary forms of Humira drugs are Humira syringes and Humira pens. Humira syringes are a form of treatment specifically used for progressive rheumatoid arthritis. The diverse applications of Humira include treating conditions such as ankylosing spondylitis, rheumatoid arthritis, Crohn's disease, and others. These drugs are employed by various end-users, including hospitals, specialty clinics, and other healthcare facilities.

The humira drugs market research report is one of a series of new reports from The Business Research Company that provides humira drugs market statistics, including humira drugs industry global market size, regional shares, competitors with a humira drugs market share, detailed humira drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the humira drugs industry. This humira drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The humira drug market size has grown strongly in recent years. It will grow from $9.19 billion in 2023 to $9.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be attributed to factors such as the introduction of biologics, advancements in biotechnology, increasing patient demand for effective treatments, and the adoption and prescribing patterns of physicians.

The humira drug market size is expected to see strong growth in the next few years. It will grow to $13.05 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to the entry of biosimilars into the market, changes in healthcare policies, a focus on cost-effectiveness, increased investments in research and development, and the emphasis on precision medicine and personalized treatments. Major trends expected in the forecast period include the generation of real-world evidence, expanded use of these medications in pediatric populations, a shift towards self-administered medications, the adoption of value-based pricing models, and the development of targeted therapies.

The humira drug market is anticipated to experience growth due to a rise in the incidence rate of autoimmune diseases. Autoimmune diseases involve the immune system attacking and damaging healthy tissues and cells in the body. Humira, a drug utilized for treating pain and inflammation caused by various autoimmune diseases, is expected to see increased demand in response to the growing incidence of autoimmune diseases. As of July 2021, statistics from Cleveland Clinics, a US-based non-profit academic medical center, reveal that 1 in 15 people in the U.S. suffer from an autoimmune disease. Notably, one million individuals in the U.S. are affected by lupus, while 1.4 million have Crohn's disease or ulcerative colitis. This surge in autoimmune diseases is poised to propel the HUMIRA drug market.

The humira drug market is also witnessing significant growth due to broad regulatory approvals granted across various countries and regions. Regulatory endorsements by governments worldwide enhance the accessibility of the humira drug globally. For instance, the U.S. Food and Drug Administration (FDA) approved an efficacy supplement for HUMIRA, extending its indication for treating pediatric patients aged 5 and above with moderately to severely active ulcerative colitis in February 2021. Additionally, in April 2023, the European Commission granted marketing authorization for a citrate-free high concentration formulation (HCF) of the biosimilar Hyrimoz (adalimumab) in the European Union. The expansive regulatory approvals for Humira contribute significantly to the ongoing growth of the humira drug market.

Product innovation stands out as a key trend in the humira drug market, with major companies developing new biologics and biosimilars to maintain their market positions. In April 2023, Sandoz, a Switzerland-based pharmaceutical company, introduced the Biosimilar Hyrimoz (adalimumab), featuring a citrate-free high-concentration formulation (HCF) approved by the European Commission. This innovative formulation provides a 50% reduction in injection volume and offers an improved experience for patients with various diseases, including rheumatic diseases and Crohn's disease.

Major companies in the humira drug market are actively focusing on the development of biosimilars for humira drugs. This strategic approach aims to enhance the cost-effectiveness of humira drugs by producing specialty biosimilars tailored for these medications. In October 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched a biosimilar of Humira, approved by the US Food and Drug Administration as interchangeable with the original product, offering a more cost-effective alternative.

In August 2023, CVS Health Corporation, a US-based pharmacy company, entered into a partnership with Sandoz Group AG, a Switzerland-based pharmaceuticals company. This collaboration aims to create a nearly identical drug at a significantly lower cost than the popular arthritis treatment Humira. The partnership establishes Cordavis, a new subsidiary of Novartis, with a primary focus on ensuring the supply of novel biosimilar medications. This strategic move positions CVS Health to compete effectively in the biosimilars market, projected to reach $100 billion in sales over the next six years.

Major companies operating in the humira drug market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

North America was the largest region in the humira drug market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the humira drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The humira drug market consists of sales of single-dose pen, a single-dose prefilled syringe, and a single-dose vial of liquid solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Humira Drug Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on humira drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for humira drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The humira drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Humira Syringe; Humira Pen
2) By Application: Ankylosing Spondylitis; Rheumatoid Arthritis; Crohn's Disease; Other Applications
3) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Fresenius Kabi AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13700

1. Executive Summary

2. Humira Drug Market Characteristics

3. Humira Drug Market Trends And Strategies

4. Humira Drug Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Humira Drug Market Size and Growth

5.1. Global Humira Drug Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Humira Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Humira Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Humira Drug Market Segmentation

6.1. Global Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Humira Syringe
Humira Pen
6.2. Global Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn's Disease
Other Applications
6.3. Global Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Other End-Users

7. Humira Drug Market Regional And Country Analysis

7.1. Global Humira Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Humira Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Humira Drug Market

8.1. Asia-Pacific Humira Drug Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Humira Drug Market

9.1. China Humira Drug Market Overview
9.2. China Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Humira Drug Market

10.1. India Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Humira Drug Market

11.1. Japan Humira Drug Market Overview
11.2. Japan Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Humira Drug Market

12.1. Australia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Humira Drug Market

13.1. Indonesia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Humira Drug Market

14.1. South Korea Humira Drug Market Overview
14.2. South Korea Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Humira Drug Market

15.1. Western Europe Humira Drug Market Overview
15.2. Western Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Humira Drug Market

16.1. UK Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Humira Drug Market

17.1. Germany Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Humira Drug Market

18.1. France Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Humira Drug Market

19.1. Italy Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Humira Drug Market

20.1. Spain Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Humira Drug Market

21.1. Eastern Europe Humira Drug Market Overview
21.2. Eastern Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Humira Drug Market

22.1. Russia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Humira Drug Market

23.1. North America Humira Drug Market Overview
23.2. North America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Humira Drug Market

24.1. USA Humira Drug Market Overview
24.2. USA Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Humira Drug Market

25.1. Canada Humira Drug Market Overview
25.2. Canada Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Humira Drug Market

26.1. South America Humira Drug Market Overview
26.2. South America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Humira Drug Market

27.1. Brazil Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Humira Drug Market

28.1. Middle East Humira Drug Market Overview
28.2. Middle East Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Humira Drug Market

29.1. Africa Humira Drug Market Overview
29.2. Africa Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Humira Drug Market Competitive Landscape And Company Profiles

30.1. Humira Drug Market Competitive Landscape
30.2. Humira Drug Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Fresenius Kabi AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Humira Drug Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Boehringer Ingelheim International GmbH
31.3. Viatris Inc.
31.4. Sandoz International GmbH
31.5. Hikma Pharmaceuticals PLC
31.6. Celltrion Healthcare Co. Ltd.
31.7. Cadila Pharmaceuticals Ltd.
31.8. Torrent Pharmaceuticals Ltd.
31.9. Mochida Pharmaceutical Co. Ltd.
31.10. Innovent Biologics Inc.
31.11. Biocad Biopharmaceutical Company
31.12. Shanghai Henlius Biotech Inc.
31.13. Glenmark Pharmaceuticals Ltd.
31.14. Samsung Bioepis Co Ltd.
31.15. Hetero Healthcare Ltd.

32. Global Humira Drug Market Competitive Benchmarking

33. Global Humira Drug Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Humira Drug Market

35. Humira Drug Market Future Outlook and Potential Analysis

35.1 Humira Drug Market In 2028 - Countries Offering Most New Opportunities
35.2 Humira Drug Market In 2028 - Segments Offering Most New Opportunities
35.3 Humira Drug Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer